BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4363010)

  • 1. A new class of angiotensin inhibitors: N-methylphenylalanine analogs.
    Peña C; Stewart JM; Goodfriend TC
    Life Sci; 1974 Apr; 14(7):1331-6. PubMed ID: 4363010
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyproline analogs of bradykinin.
    Stewart JM; Ryan JW; Brady AH
    J Med Chem; 1974 May; 17(5):537-9. PubMed ID: 4830258
    [No Abstract]   [Full Text] [Related]  

  • 3. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
    Paiva AC; Nouailhetas VL; Paiva TB
    J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II.
    Paiva TB; Paiva AC; Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
    Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
    J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of (5-valine,7-N-methylalanine)-angiotensin II, a hypertensive peptide.
    Andreatta RH; Scheraga HA
    J Med Chem; 1971 Jun; 14(6):489-92. PubMed ID: 4327021
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II analogs. II. Cyclo-(-Val-Tyr-Ile-His-Pro-Phe-).
    Jorgensen EC; Patton W
    J Med Chem; 1969 Sep; 12(5):935-6. PubMed ID: 4309508
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II analogues. 12. Role of the aromatic ring of position 8 phenylalanine in pressor activity.
    Hsieh K; Jorgensen EC; Lee TC
    J Med Chem; 1979 Sep; 22(9):1038-44. PubMed ID: 490548
    [No Abstract]   [Full Text] [Related]  

  • 11. The stability of angiotensinamide in the presence of urea.
    Constantine JW
    Experientia; 1964 Jul; 20(7):381-2. PubMed ID: 4285395
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II analogs. 11. Further studies on des-aspartyl-angiotensin II.
    Jorgensen EC; Kiraly-Olah IC; Lee TC; Windridge GC
    J Med Chem; 1974 Mar; 17(3):323-6. PubMed ID: 4359545
    [No Abstract]   [Full Text] [Related]  

  • 13. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.
    Matsoukas J; Cordopatis P; Belte U; Goghari MH; Ganter RC; Franklin KJ; Moore GJ
    J Med Chem; 1988 Jul; 31(7):1418-21. PubMed ID: 2455051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation constant of angiotensin II as determined by the use of an irreversible specific inhibitor (1-Sar-8-Leu-AT II ).
    Regoli D; Rioux F; Park WK
    Rev Can Biol; 1972 Mar; 31(1):73-7. PubMed ID: 4336058
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiotensin blockade and hypertension].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2396-7. PubMed ID: 4374772
    [No Abstract]   [Full Text] [Related]  

  • 17. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
    Moore G; Oudeman E; Gorman P
    Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin II analogs. I. Synthesis and biological evaluation of [Gly-1,Gly-2,Ile-5]-angiotensin II, [Ac-Gly-1,Gly-2,Ile-5]-angiotensin II, and [Gly-1,Gly-2,Ile-5,His(Bzl)-6]-angiotensin II.
    Jorgensen EC; Windridge GC; Patton W
    J Med Chem; 1969 Sep; 12(5):733-7. PubMed ID: 4309507
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular permeability factor: dissociation from the angiotensin II induced pressor and drinking responses.
    Vaughan ED; Gavras H; Laragh JH; Koss MN
    Nature; 1973 Mar; 242(5396):334-5. PubMed ID: 4349236
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Angiotensin inhibition.
    Chobanian AV
    N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.